CELLVIR

A 100% OWNED SUBSIDIARY OF PHARMA OMNIUM INTERNATIONAL

CELLVIR IS AN ENTITY FOCUSING ON THE DEVELOPMENT OF BREAKTHROUGH ANTI HIV THERAPIES

THE CORE RESEARCH PROJECTS OF CELLVIR CONCENTRATE ON TARGETING THE HOST-VIRUS PROTEIN-PROTEIN INTERACTIONS WICH HAVE BEEN SHOWN TO BE ESSENTIAL FOR VIRAL REPLICATION IN INFECTED CELLS

FOR BUSINESS DEVELOPMENT ISSUES AND SCIENTIFIC MATTERS PLEASE CONTACT US AT:  info@mutabilis.com